RIVKAH HOROWITZ: Open Payments
NPI 1639303084 · TIMONIUM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,340 in 57 payments from 27 companies in 2025. Trend: 2023 $1,212 · 2024 $1,623 · 2025 $1,340
Food & beverage: $1,340
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $192 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $150 |
| GENZYME CORPORATION | 1 | $113 |
| Ascendis Pharma Endocrinology Inc | 3 | $78 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $77 |
| Alexion Pharmaceuticals, Inc. | 3 | $72 |
| Radius Health, Inc. | 3 | $56 |
| BETA BIONICS, INC. | 2 | $54 |
| Novo Nordisk Inc | 3 | $53 |
| SANOFI-AVENTIS U.S. LLC | 2 | $53 |
Products named: Kerendia, FABRAZYME, QULIPTA, Yorvipath, ISTURISA, STRENSIQ, SYNTHROID, iLet Bionic Pancreas.
Industry payments across MD — which companies pay providers there.
